Literature DB >> 11480785

Genetic heterogeneity of beta-thalassemia at Cukurova in southern Turkey.

M A Cürük1, A Arpaci, G Attila, A Tuli, Y Kilinç, K Aksoy, G T Yüreğir.   

Abstract

Beta-thalassemia is the most common genetic abnormality causing health problems worldwide. Cukurova, in the southern part of Turkey, being on the Mediterranean, is in the thalassemic belt. Since there is no cure for the disease at present, the frequency of the mutation types of beta-thalassemia must first be identified to aid in clinical follow-up and prenatal diagnosis. Carriers identified during a screening survey and patients referred to our laboratory were studied for this purpose. After routine hematological analysis molecular screening was performed by the amplification refractory mutation system and DNA sequencing. The frequency of the common mutations were: IVS-I-110 (G-->A) 57.3%, IVS-I-1 (G-->A) 8.3%, codon 39 (C-->T) 6.4%, IVS-I-6 (T-->C) 5.7%, frameshift codon 8 (-AA) 5.7%, -30 (T-->A) 4.7%, IVS-II-1 (G-->A) 3.4%, IVS-II-745 (G-->C) 2.8%, and frameshift codon 5 (-CT) 1.1%. Some rare mutations (1%) such as frameshift codon 44 (-C) 0.7%, frameshift codons 74/75 (-C) 0.7%, IVS-1-5 (G-->C) 0.7%, frameshift codons 8/9 (+G) 0.4%, frameshift codons 36/37 (-T) 0.4%, frameshift codons 22/23/24 (-AAGTTGG) 0.4%, IVS-1-130 (G-->C) 0.4%, IVS-1-5 (G-->T) 0.2%, -28 (A-->C) 0.2%, codon 15 (TGG-->TGA) 0.2%, and frameshift codons 82/83 (-G) 0.2%, were detected by sequence analysis. The codon 15 (TGG-->TGA) and frameshift codons 82/83 (-G) mutations were seen in Turkey for the first time.

Entities:  

Mesh:

Year:  2001        PMID: 11480785     DOI: 10.1081/hem-100104032

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.

Authors:  Yeşim Aydınok; Yeşim Oymak; Berna Atabay; Gönül Aydoğan; Akif Yeşilipek; Selma Ünal; Yurdanur Kılınç; Banu Oflaz; Mehmet Akın; Canan Vergin; Melike Sezgin Evim; Ümran Çalışkan; Şule Ünal; Ali Bay; Elif Kazancı; Talia İleri; Didem Atay; Türkan Patıroğlu; Selda Kahraman; Murat Söker; Mediha Akcan; Aydan Akdeniz; Mustafa Büyükavcı; Güçhan Alanoğlu; Özcan Bör; Nur Soyer; Nihal Özdemir Karadaş; Ezgi Uysalol; Meral Türker; Arzu Akçay; Süheyla Ocak; Adalet Meral Güneş; Hüseyin Tokgöz; Elif Ünal; Naci Tiftik; Zeynep Karakaş
Journal:  Turk J Haematol       Date:  2017-04-13       Impact factor: 1.831

2.  β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study.

Authors:  Birol Guvenc; Abdullah Canataroglu; Cagatay Unsal; Sule Menziletoglu Yildiz; Ferda Tekin Turhan; Sevcan Tug Bozdogan; Suleyman Dincer; Hakan Erkman
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

3.  Two Rare Pathogenic HBB Variants in a Patient with β-Thalassemia Intermedia

Authors:  Veysel Sabri Hançer; Tunç Fışgın; Murat Büyükdoğan
Journal:  Turk J Haematol       Date:  2020-02-19       Impact factor: 1.831

4.  Relationship of SARS-CoV-2 Pandemic with Blood Groups.

Authors:  Didar Yanardag Acik; Mehmet Bankir
Journal:  Transfus Med Hemother       Date:  2021-04-07       Impact factor: 3.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.